Welcome to Part 2 of the 2022 Forum on Complement Case Discussion Series. PNH is an ultra-rare, and under-recognized complement-mediated disease. Despite its rarity this disease warrants our attention because…

Introduction Welcome to the second installment of the three- part CARE™ nmCRPC Case Series! This series aims to provide context and guidance on how to navigate the evolving treatment landscape...

7th annual CCH-QC was held in virtually on April 28. The meeting is directed at QC and francophone clinicians. Content is available for access by clicking on the box above.

CARE™ has been busy! See below the recent work from the CARE™ Oncology Faculty, featuring reports and video discussions.

The CARE™ Prostate Cancer Faculty reviews important plenary session content and data presented from various conferences throughout the year. Recent clinical trial updates presented at the beginning of the 2022…

Welcome to the Part 1 of the 2022 Forum on Complement Case Discussion.

Introduction Welcome to the first installment of the three- part CARE™ nmCRPC Case Series! This series aims to provide context and guidance on how to navigate the evolving treatment landscape...

The CARE™ Winter Hematology Update Conference Report 2022.

Introduction Treatment of Frontline CLL has dramatically evolved in the last decade. As the number of novel options and strategies available to us continues to grow, treatment decisions have become...

Introduction In this segment, CARE™ Hematology Faculty member, Dr. Matthew Kang (Joseph Brant Hospital) is joined by cardiologist, Dr. Christian Constance (HMR) to discuss management of Cardiovascular AE’s associated with...